Cargando…

Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy

Non-ischemic dilated cardiomyopathy encompasses a wide spectrum of myocardial disorders, characterized by left ventricular dilatation with systolic impairment and increased risk of sudden cardiac death. In spite of all the therapeutic progress that has been made in recent years, dilated cardiomyopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anghel, Larisa, Sascău, Radu, Zota, Ioana Mădălina, Stătescu, Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198011/ https://www.ncbi.nlm.nih.gov/pubmed/34073616 http://dx.doi.org/10.3390/ijms22115688

Ejemplares similares

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
por: Anghel, Larisa, et al.
Publicado: (2020)

The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update
por: Sascău, Radu, et al.
Publicado: (2021)

From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis
por: Anghel, Larisa, et al.
Publicado: (2020)

The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19
por: Anghel, Larisa, et al.
Publicado: (2022)

Post-Myocardial Infarction Ventricular Remodeling Biomarkers—The Key Link between Pathophysiology and Clinic
por: Bostan, Maria-Madălina, et al.
Publicado: (2020)

The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy
por: Anghel, Larisa, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Short-Term CPAP Improves Biventricular Function in Patients with Moderate-Severe OSA and Cardiometabolic Comorbidities
por: Zota, Ioana Mădălina, et al.
Publicado: (2021)

A Systematic Review on the Risk Modulators of Myocardial Infarction in the “Young”—Implications of Lipoprotein (a)
por: Stătescu, Cristian, et al.
Publicado: (2023)

Arterial Stiffness Assessment Using the Arteriograph in Patients with Moderate–Severe OSA and Metabolic Syndrome—A Pilot Study
por: Zota, Ioana Mădălina, et al.
Publicado: (2021)

From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
por: Stătescu, Cristian, et al.
Publicado: (2022)

Long-Term Adherence in Overweight Patients with Obstructive Sleep Apnea and Hypertension—A Pilot Prospective Cohort Study
por: Zota, Ioana Madalina, et al.
Publicado: (2023)

Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

In search of lost time – a case of myocardial perforation in a patient with arrhythmogenic right ventricular cardiomyopathy
por: Ureche, Carina, et al.
Publicado: (2021)

Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness—A Narrative Review
por: Zota, Ioana Mădălina, et al.
Publicado: (2022)

Review of Echocardiographic Findings in Patients with Obstructive Sleep Apnea
por: Sascău, Radu, et al.
Publicado: (2018)

CPAP Influence on Readily Available Inflammatory Markers in OSA—A Pilot Study
por: Zota, Ioana Madalina, et al.
Publicado: (2022)

CPAP Effect on Cardiopulmonary Exercise Testing Performance in Patients with Moderate-Severe OSA and Cardiometabolic Comorbidities
por: Zota, Ioana Mădălina, et al.
Publicado: (2020)

What can hide behind an “idiopathic” dilated cardiomyopathy?
por: Țăpoi, Laura, et al.
Publicado: (2021)

Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
por: Stătescu, Cristian, et al.
Publicado: (2021)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review
por: Sascău, Radu, et al.
Publicado: (2021)

Consensus and Controversy in the Debate over the Biphasic Impact of Alcohol Consumption on the Cardiovascular System
por: Stătescu, Cristian, et al.
Publicado: (2021)

Uric Acid—An Emergent Risk Marker for Thrombosis?
por: Țăpoi, Laura, et al.
Publicado: (2021)

The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence
por: Dimache, Alina Mihaela, et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field
por: Adam, Cristina Andreea, et al.
Publicado: (2022)

Impact of HVAC-Systems on the Dispersion of Infectious Aerosols in a Cardiac Intensive Care Unit
por: Anghel, Larisa, et al.
Publicado: (2020)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients
por: Ureche, Carina, et al.
Publicado: (2023)

Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification
por: Ferreira, André, et al.
Publicado: (2023)

The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions
por: Popa, Delia Melania, et al.
Publicado: (2023)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients
por: Ureche, Carina, et al.
Publicado: (2023)

Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3q1blmbpo7i4kupmblvltr7oef